These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31887722)

  • 41. Intrauterine adhesions.
    Berman JM
    Semin Reprod Med; 2008 Jul; 26(4):349-55. PubMed ID: 18756412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone Marrow Mesenchymal Stem Cells (BMSCs) Restore Functional Endometrium in the Rat Model for Severe Asherman Syndrome.
    Gao L; Huang Z; Lin H; Tian Y; Li P; Lin S
    Reprod Sci; 2019 Mar; 26(3):436-444. PubMed ID: 30458678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman's syndrome.
    Yu D; Li TC; Xia E; Huang X; Liu Y; Peng X
    Fertil Steril; 2008 Mar; 89(3):715-22. PubMed ID: 17681324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strategies for managing Asherman's syndrome and endometrial atrophy: Since the classical experimental models to the new bioengineering approach.
    de Miguel-Gómez L; Romeu M; Pellicer A; Cervelló I
    Mol Reprod Dev; 2021 Aug; 88(8):527-543. PubMed ID: 34293229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.
    Bosteels J; Kasius J; Weyers S; Broekmans FJ; Mol BW; D'Hooghe TM
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009461. PubMed ID: 25701429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.
    Bosteels J; Kasius J; Weyers S; Broekmans FJ; Mol BW; D'Hooghe TM
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009461. PubMed ID: 23440838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B; Havelock J; Hemmings R; ;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endometrial autotransplantation in rabbits: Potential for fertility restoration in severe Asherman's syndrome.
    Jones BP; Vali S; Saso S; Garcia-Dominguez X; Chan M; Thum MY; Ghaem-Maghami S; Kaur B; García-Valero L; Petrucci L; Yazbek J; Vicente JS; Quiroga I; Marco-Jiménez F; Smith JR
    Eur J Obstet Gynecol Reprod Biol; 2020 May; 248():14-23. PubMed ID: 32171148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regenerating endometrium from stem/progenitor cells: is it abnormal in endometriosis, Asherman's syndrome and infertility?
    Deane JA; Gualano RC; Gargett CE
    Curr Opin Obstet Gynecol; 2013 Jun; 25(3):193-200. PubMed ID: 23562953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Novel Ultrasound-Guided Technique for Hysteroscopic Adhesiolysis in High-Risk Patients.
    Kriseman M; Schutt A; Appleton J; Pillai A; George V; Zarutskie PW
    J Ultrasound Med; 2019 May; 38(5):1383-1387. PubMed ID: 30208242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of de novo adhesion formation in patients with Asherman's syndrome.
    BarboraBoudová Barbora; Lisá Zdeňka; Richtárová Adéla; Kužel D; MichalMára Michal
    Ceska Gynekol; 2021; 86(4):273-278. PubMed ID: 34493053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-Mullerian hormone as a parameter for endometrial trauma in Asherman syndrome: A retrospective data analysis.
    Promberger R; Ott J
    Reprod Biol; 2017 Jun; 17(2):151-153. PubMed ID: 28400095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A cohort study comparing 4 mg and 10 mg daily doses of postoperative oestradiol therapy to prevent adhesion reformation after hysteroscopic adhesiolysis.
    Liu L; Huang X; Xia E; Zhang X; Li TC; Liu Y
    Hum Fertil (Camb); 2019 Sep; 22(3):191-197. PubMed ID: 29504823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endometrial thickness measured by ultrasound scan in women with uterine outlet obstruction due to intrauterine or upper cervical adhesions.
    Lo ST; Ramsay P; Pierson R; Manconi F; Munro MG; Fraser IS
    Hum Reprod; 2008 Feb; 23(2):306-9. PubMed ID: 18083747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hysteroscopic Management of Asherman's Syndrome.
    Khan Z; Goldberg JM
    J Minim Invasive Gynecol; 2018 Feb; 25(2):218-228. PubMed ID: 29024798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hysteroscopic appearance of the endometrial cavity following thermal balloon endometrial ablation.
    Leung PL; Tam WH; Yuen PM
    Fertil Steril; 2003 May; 79(5):1226-8. PubMed ID: 12738523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of the inflammation and fibrosis in Asherman syndrome rat model by mesenchymal stem cells: histological and immunohistochemical studies.
    Salama NM; Zaghlol SS; Mohamed HH; Kamar SS
    Folia Histochem Cytobiol; 2020; 58(3):208-218. PubMed ID: 32996119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Intrauterine adhesions--Asherman's syndrome].
    Heinonen PK
    Duodecim; 2010; 126(21):2486-91. PubMed ID: 21171473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hystroscopic management of Ashermans syndrome.
    Yasmin H; Nasir A; Noorani KJ
    J Pak Med Assoc; 2007 Nov; 57(11):553-5. PubMed ID: 18062521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reproductive outcome following treatment of intrauterine adhesions in Abuja, Nigeria.
    Efetie ER
    Niger J Clin Pract; 2006 Dec; 9(2):164-8. PubMed ID: 17319351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.